BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 9525341)

  • 21. Isolation and characterization of two disintegrins inhibiting ADP-induced human platelet aggregation from the venom of Crotalus scutulatus scutulatus (Mohave Rattlesnake).
    Sánchez EE; Galán JA; Russell WK; Soto JG; Russell DH; Pérez JC
    Toxicol Appl Pharmacol; 2006 Apr; 212(1):59-68. PubMed ID: 16084550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
    Shahan TA; Ziaie Z; Pasco S; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
    Cancer Res; 1999 Sep; 59(18):4584-90. PubMed ID: 10493512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression.
    Zhou Q; Sherwin RP; Parrish C; Richters V; Groshen SG; Tsao-Wei D; Markland FS
    Breast Cancer Res Treat; 2000 Jun; 61(3):249-60. PubMed ID: 10966001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy.
    Carron CP; Meyer DM; Pegg JA; Engleman VW; Nickols MA; Settle SL; Westlin WF; Ruminski PG; Nickols GA
    Cancer Res; 1998 May; 58(9):1930-5. PubMed ID: 9581835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrin receptor-mediated mobilisation of intranuclear calcium in rat osteoclasts.
    Shankar G; Davison I; Helfrich MH; Mason WT; Horton MA
    J Cell Sci; 1993 May; 105 ( Pt 1)():61-8. PubMed ID: 7689577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a beta 3 integrin.
    Helfrich MH; Nesbitt SA; Dorey EL; Horton MA
    J Bone Miner Res; 1992 Mar; 7(3):335-43. PubMed ID: 1585836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Echistatin is a potent inhibitor of bone resorption in culture.
    Sato M; Sardana MK; Grasser WA; Garsky VM; Murray JM; Gould RJ
    J Cell Biol; 1990 Oct; 111(4):1713-23. PubMed ID: 2211834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leberagin-C, A disintegrin-like/cysteine-rich protein from Macrovipera lebetina transmediterranea venom, inhibits alphavbeta3 integrin-mediated cell adhesion.
    Limam I; Bazaa A; Srairi-Abid N; Taboubi S; Jebali J; Zouari-Kessentini R; Kallech-Ziri O; Mejdoub H; Hammami A; El Ayeb M; Luis J; Marrakchi N
    Matrix Biol; 2010 Mar; 29(2):117-26. PubMed ID: 19808093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of kistrin on bone resorption in vitro and serum calcium in vivo.
    King KL; D'Anza JJ; Bodary S; Pitti R; Siegel M; Lazarus RA; Dennis MS; Hammonds RG; Kukreja SC
    J Bone Miner Res; 1994 Mar; 9(3):381-7. PubMed ID: 8191932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity studies of the s-echistatin inhibition of bone resorption.
    Sato M; Garsky V; Majeska RJ; Einhorn TA; Murray J; Tashjian AH; Gould RJ
    J Bone Miner Res; 1994 Sep; 9(9):1441-9. PubMed ID: 7817829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone.
    Carron CP; Meyer DM; Engleman VW; Rico JG; Ruminski PG; Ornberg RL; Westlin WF; Nickols GA
    J Endocrinol; 2000 Jun; 165(3):587-98. PubMed ID: 10828842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts.
    Horton MA; Taylor ML; Arnett TR; Helfrich MH
    Exp Cell Res; 1991 Aug; 195(2):368-75. PubMed ID: 1712731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor.
    Jones JI; Prevette T; Gockerman A; Clemmons DR
    Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2482-7. PubMed ID: 8637900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of osteoclast-mediated bone resorption through occupancy of the integrin receptor: a potential approach to the therapy of osteoporosis.
    Dresner-Pollak R; Rosenblatt M
    J Cell Biochem; 1994 Nov; 56(3):323-30. PubMed ID: 7876325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different regions of the class P-III snake venom metalloproteinase jararhagin are involved in binding to alpha2beta1 integrin and collagen.
    Tanjoni I; Evangelista K; Della-Casa MS; Butera D; Magalhães GS; Baldo C; Clissa PB; Fernandes I; Eble J; Moura-da-Silva AM
    Toxicon; 2010 Jun; 55(6):1093-9. PubMed ID: 20056118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrins and osteoclastic resorption in three bone organ cultures: differential sensitivity to synthetic Arg-Gly-Asp peptides during osteoclast formation.
    van der Pluijm G; Mouthaan H; Baas C; de Groot H; Papapoulos S; Löwik C
    J Bone Miner Res; 1994 Jul; 9(7):1021-8. PubMed ID: 7942148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein.
    Fisher JE; Caulfield MP; Sato M; Quartuccio HA; Gould RJ; Garsky VM; Rodan GA; Rosenblatt M
    Endocrinology; 1993 Mar; 132(3):1411-3. PubMed ID: 8440195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Vitaxin, a novel therapeutic in trial for metastatic bone tumors, on osteoclast functions in vitro.
    Gramoun A; Shorey S; Bashutski JD; Dixon SJ; Sims SM; Heersche JN; Manolson MF
    J Cell Biochem; 2007 Oct; 102(2):341-52. PubMed ID: 17390341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone.
    Nakamura I; Pilkington MF; Lakkakorpi PT; Lipfert L; Sims SM; Dixon SJ; Rodan GA; Duong LT
    J Cell Sci; 1999 Nov; 112 ( Pt 22)():3985-93. PubMed ID: 10547359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disintegrins extracted from totonacan rattlesnake (Crotalus totonacus) venom and their anti-adhesive and anti-migration effects on MDA-MB-231 and HMEC-1 cells.
    Rivas Mercado E; Neri Castro E; Bénard Valle M; Rucavado-Romero A; Olvera Rodríguez A; Zamudio Zuñiga F; Alagón Cano A; Garza Ocañas L
    Toxicol In Vitro; 2020 Jun; 65():104809. PubMed ID: 32087267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.